An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti–Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad329 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Arnaud Chêne und 5 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, BIGR, Université Paris Cité, and Université des Antilles. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme 2, Antibodies, Viral, COVID-19, Herpesvirus 4, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: ERGANEO, IdEX Université Paris Cité, Institut National de la Santé et de la Recherche Médicale.
Abstract (Originalsprache)
The use of soluble recombinant angiotensin-converting enzyme 2 (rACE2) as a decoy capable of blocking SARS-CoV-2 entry into cells has been envisaged as a therapeutic strategy to reduce viral loads in patients with severe COVID-19. We engineered a novel form of rACE2, fused to the Epstein-Barr virus antigen P18F3 (rACE2-P18F3), to reorient a preexisting humoral response toward Epstein-Barr virus against SARS-CoV-2 particles. Recombinant ACE2-P18F3 was able to bind to the SARS-CoV-2 spike protein, neutralize viral entry into cells, and promote the phagocytosis of spheres coated with different spike variants by monocytic cells. The results position rACE2-P18F3 as a promising therapeutic candidate to universally block coronavirus cell entry and clear viral particles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM, BIGR, Université Paris Cité, and Université des Antilles.
- Innovation Lab: Vaccines, Institut Pasteur, Université Paris Cité, Paris, France.
ORCID-Profile: Arnaud Chêne
Förderung
- ERGANEO
- IdEX Université Paris Cité
- Institut National de la Santé et de la Recherche Médicale
- PARAFRAP ANR-11-LABEX-0024-01
Zitieren
APA
Chêne, A., Desrames, A., Tomlinson, A., Ruffié, C., Tangy, F., & Gamain, B. (2023). An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti–Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad329
Vancouver
Chêne A, Desrames A, Tomlinson A, Ruffié C, Tangy F, Gamain B. An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti–Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad329
BibTeX
@article{Chne2023,
author = {Chêne, Arnaud and Desrames, Alexandra and Tomlinson, Alice and Ruffié, Claude and Tangy, Frédéric and Gamain, Benoît},
title = {An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti–Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad329}
}
EUVIMED